NCT05313295

Brief Summary

To evaluate the positive effects of a home-based physical therapy intervention added to the usual physical therapy programs performed in children with neurological pathologies that induce sensorimotor impairments that affect their quality of life and the importance of the implications of their families in their treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 6, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2023

Completed
Last Updated

May 23, 2023

Status Verified

May 1, 2023

Enrollment Period

4.1 years

First QC Date

February 27, 2022

Last Update Submit

May 22, 2023

Conditions

Keywords

ChildhoodNeurologic disorderDuchenne

Outcome Measures

Primary Outcomes (1)

  • Motor Function Measure

    Measurement scale for motor function applied to neuromuscular diseases (MFM): It was created in France in order to perform a better evaluation of global motor function in patients with Duchenne's muscular dystrophy (DMD), both for ambulatory and non-ambulatory patients. It has two versions, MFM 20 for children under 6 years of age and MFM 32 for children over 6 years of age. The scale considers three dimensions: (D1) standing station and transfers; (D2) axial and proximal motor skills and (D3) distal motor skills. The sum of the three results in a global percentage that provides an updated overview of the patient's functional diagnosis. (Trundell et al., 2020)

    One Year

Secondary Outcomes (4)

  • Brooke Upper Extremity Scale

    One Year

  • Vignos Scale

    One Year

  • Timed Up and Go Test

    One Year

  • Six Minutes Walk Distance

    One Year

Study Arms (2)

Home-based Physiotherapy

EXPERIMENTAL

Two days a week of physical therapy (mobilizations, manual therapy, stretching, respiratory techniques) + 3 hours extra of home-based physiotherapy (stretching, active mobilizations)

Other: Home-based physiotherapy

Usual physiotherapy

ACTIVE COMPARATOR

Two days a week of physical therapy (mobilizations, manual therapy, stretching, respiratory techniques)

Other: Usual Physiotherapy

Interventions

Manual Therapy, passive and active mobilizations, stretching, respiratory techniques

Home-based Physiotherapy

Usual care provided for the management of neurological disorders in children

Usual physiotherapy

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Parents agree to include their children on the study
  • Affiliated to the Duchenne Parents Project Association (Spain)
  • Between 3-18 years old

You may not qualify if:

  • Other pathological conditions
  • Parents refuse the participation on the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

María del Mar Sánchez-Joya

Almería, 04120, Spain

Location

Related Publications (5)

  • Alemdaroglu I, Karaduman A, Yilmaz OT, Topaloglu H. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation. Muscle Nerve. 2015 May;51(5):697-705. doi: 10.1002/mus.24451. Epub 2015 Mar 5.

    PMID: 25196721BACKGROUND
  • Alkan H, Mutlu A, Firat T, Bulut N, Karaduman AA, Yilmaz OT. Effects of functional level on balance in children with Duchenne Muscular Dystrophy. Eur J Paediatr Neurol. 2017 Jul;21(4):635-638. doi: 10.1016/j.ejpn.2017.02.005. Epub 2017 Feb 20.

    PMID: 28259452BACKGROUND
  • Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P. Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation. Health Technol Assess. 2017 May;21(27):1-120. doi: 10.3310/hta21270.

    PMID: 28627356BACKGROUND
  • Goemans N, Vanden Hauwe M, Signorovitch J, Swallow E, Song J; Collaborative Trajectory Analysis Project (cTAP). Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy. PLoS One. 2016 Oct 13;11(10):e0164684. doi: 10.1371/journal.pone.0164684. eCollection 2016.

    PMID: 27737016BACKGROUND
  • Jansen M, van Alfen N, Geurts AC, de Groot IJ. Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse". Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):816-27. doi: 10.1177/1545968313496326. Epub 2013 Jul 24.

    PMID: 23884013BACKGROUND

MeSH Terms

Conditions

Nervous System DiseasesMuscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • María del Mar Sánchez-Joya, PhD

    Universidad de Almeria

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 27, 2022

First Posted

April 6, 2022

Study Start

November 1, 2018

Primary Completion

November 30, 2022

Study Completion

May 10, 2023

Last Updated

May 23, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Shared Documents
SAP
Time Frame
Data will become available for one year once the study is finished
Access Criteria
Reasonable request to reproduce the intervention performed on this study

Locations